Jury Says Illumina Infringed Five Affy Patents; Awards $16.7M in Damages | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
One week after a patent infringement trial filed by Affymetrix against Illumina began, a jury for the US District Court for the District of Delaware has said that Illumina infringed all five Affymetrix patents at issue in the case and has awarded Affymetrix $16.7 million in damages.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Harold Varmus, a former NIH director, says that proposed reductions to the agency's budget are worrisome.

The Genome 10K project is to sequence about 10,000 vertebrate genomes, including ones of endangered species, Digital Trends reports.

The new Coalition to Save NIH Funding aims to educate lawmakers and the public on the significance of biomedical research.

In PLOS this week: analysis of viral sequences from human blood samples, gut microbiomes of heart failure patients, and more.